Replies to post #131897 on Biotech Values

[DewDiligence]

The same newspaper reported yesterday that atorvastatin was already shipped to the US by Teva.

The FDA’s PR in #msg-69479502 names Ohm Laboratories of New Jersey as the manufacturer of Ranbaxy’s generic Lipitor. If Teva is really producing Ranbaxy’s Lipitor, then Ohm is presumably just the fill/finish contractor for the product.

[DewDiligence]

Teva’s Lipitor was evidently just a backup plan for Ranbaxy, and Ohm Laboratories of NJ is the manufacturer of Ranbaxy’s Lipitor. However, Teva is nonetheless getting a cut of Ranbaxy’s sales.

http://www.bloomberg.com/news/2011-12-02/ranbaxy-falls-after-teva-says-it-won-t-supply-lipitor-ingredient.html

Nice gig for Teva! It’s like financiers who get a “standby” fee even if their credit line is never tapped.